Press Releases March 26, 2026 09:30 AM

Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China

Visionary Holdings partners with Zhejiang Chushanji to expand distribution of V-series anti-aging products across China's extensive offline retail network.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
GV

Visionary Holdings Inc. (NASDAQ: GV) has entered a strategic cooperation with China-based Zhejiang Chushanji Digital Technology Co., Ltd. to leverage their offline distribution network across multiple Chinese provinces for marketing and selling Visionary's V-series anti-aging products. The collaboration targets increased market penetration within medical aesthetics and wellness service locations, potentially contributing $10-15 million annually, though subject to uncertainties.

Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China
GV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Strategic partnership with Zhejiang Chushanji to utilize its network of nearly 10,000 stores across 5 Chinese provinces.
  • Focus on expanding distribution and sales of V-series anti-aging products in medical aesthetics and wellness sectors.
  • Potential annual revenue impact estimated between $10 million to $15 million if market adoption meets expectations.

HONG KONG, March 26, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (the “Company” or “Visionary”) , a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that it has entered into a strategic cooperation agreement with Zhejiang Chushanji Digital Technology Co., Ltd. (“Chushanji”), a China-based enterprise engaged in digital marketing, brand services, and offline network operations.

According to information provided by Chushanji, the company currently operates an extensive offline commercial network spanning 5 provinces and 105 district- and county-level markets in China, covering nearly 10,000 stores.

Pursuant to the agreement, Chushanji is expected to assist Visionary in the marketing, channel development, distribution, and sales support of the Company’s V-series anti-aging products in China. By leveraging Chushanji’s existing offline business network and operational resources, the cooperation is intended to facilitate product promotion, channel penetration, and potential customer conversion across selected medical aesthetics and wellness service locations.

Chushanji has developed an offline service network through its ongoing business activities, which may provide Visionary with access to a broad base of service locations and consumer touchpoints. Through this cooperation, the Company expects to explore scalable approaches for expanding market awareness and supporting the commercialization of its V-series anti-aging products in the Chinese market.

Based on preliminary internal estimates, the Company believes that, if the collaboration progresses as expected and market adoption is achieved, annual revenue contribution from related products could potentially reach a range of approximately $10 million to $15 million over time. Such estimates are subject to significant uncertainties, including market demand, execution, channel performance, and regulatory factors, and there can be no assurance that such results will be achieved.

Mr. Xiyong Hou, Chief Executive Officer of Visionary Holdings Inc., commented:
“This cooperation represents an important step in advancing the market rollout of our V-series anti-aging products in China. By working with a partner that has established experience in offline network operations and channel development, we aim to strengthen our product distribution capabilities, improve market access, and support our broader commercialization strategy in the medical aesthetics and wellness sector. Based on our preliminary internal assessments, we believe this cooperation may create a meaningful commercial opportunity over time, although actual results will depend on the pace of execution and market acceptance.”

The Company notes that the cooperation is currently at an initial stage, and there can be no assurance regarding the timing, scale, or financial impact of the collaboration.

About Visionary Holdings Inc.
Visionary Holdings Inc. (Nasdaq: GV) is a technology-driven multinational enterprise focused on AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond GV's control, which may cause GV's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to GV as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in GV's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. GV does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Contacts:

Visionary Holdings Inc.
Investor Relations
Email: IR@visionary.holdings


Risks

  • Success depends on effective execution, market demand, and channel performance in China’s complex regulatory environment.
  • Uncertainties related to timing, scale, and financial outcomes of the cooperation remain significant.
  • Potential impacts from regulatory changes in China or shifts in consumer preference within the healthcare and wellness sectors.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026